The prognosis for GBM patients is generally poor, with a median survival rate of about 15 months, despite aggressive treatment. Factors such as the patient's age, overall health, and the tumor's genetic profile can influence outcomes. Ongoing research aims to improve these statistics through novel therapies and personalized treatment approaches.
